Literature DB >> 8978636

Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach.

B Alfano1, A Brunetti, E M Covelli, M Quarantelli, M R Panico, A Ciarmiello, M Salvatore.   

Abstract

The purpose of this study was the development and testing of a method for unsupervised, automated brain segmentation. Two spin-echo sequences were used to obtain relaxation rates and proton-density maps from 1.5 T MR studies, with two axial data sets including the entire brain. Fifty normal subjects (age range, 16 to 76 years) were studied. A Three-dimensional (3D) spectrum of the tissue voxels was used for automatic segmentation of gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) and for calculation of their volumes. Accuracy and reproducibility were tested with a three-compartment phantom simulating GM, WM, and CSF. In the normal subjects, a significant decrease of GM fractional volume and increased CSF volume with age were observed (P < 0.0001), with no significant changes in WM. This multispectral segmentation method permits reproducible, operator-independent volumetric measurements.

Mesh:

Year:  1997        PMID: 8978636     DOI: 10.1002/mrm.1910370113

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  25 in total

1.  Novel whole brain segmentation and volume estimation using quantitative MRI.

Authors:  J West; J B M Warntjes; P Lundberg
Journal:  Eur Radiol       Date:  2011-11-24       Impact factor: 5.315

Review 2.  Segmentation of human brain using structural MRI.

Authors:  Gunther Helms
Journal:  MAGMA       Date:  2016-01-06       Impact factor: 2.310

3.  A hybrid tissue segmentation approach for brain MR images.

Authors:  Tao Song; Charles Gasparovic; Nancy Andreasen; Jeremy Bockholt; Mo Jamshidi; Roland R Lee; Mingxiong Huang
Journal:  Med Biol Eng Comput       Date:  2006-02-17       Impact factor: 2.602

4.  Neuroprotective effects of riluzole in Huntington's disease.

Authors:  Ferdinando Squitieri; Andrea Ciammola; Claudio Colonnese; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-06       Impact factor: 9.236

5.  Semiautomatic regional segmentation to measure orbital fat volumes in thyroid-associated ophthalmopathy. A validation study.

Authors:  M Comerci; A Elefante; D Strianese; R Senese; P Bonavolontà; B Alfano; B Bonavolontà; A Brunetti
Journal:  Neuroradiol J       Date:  2013-08-27

Review 6.  Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains.

Authors:  Andrew L Alexander; Samuel A Hurley; Alexey A Samsonov; Nagesh Adluru; Ameer Pasha Hosseinbor; Pouria Mossahebi; Do P M Tromp; Elizabeth Zakszewski; Aaron S Field
Journal:  Brain Connect       Date:  2012-01-27

7.  The effects of changing water content, relaxation times, and tissue contrast on tissue segmentation and measures of cortical anatomy in MR images.

Authors:  Ravi Bansal; Xuejun Hao; Feng Liu; Dongrong Xu; Jun Liu; Bradley S Peterson
Journal:  Magn Reson Imaging       Date:  2013-09-20       Impact factor: 2.546

8.  Automated determination of brain parenchymal fraction in multiple sclerosis.

Authors:  M Vågberg; T Lindqvist; K Ambarki; J B M Warntjes; P Sundström; R Birgander; A Svenningsson
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

9.  Standardized, reproducible, high resolution global measurements of T1 relaxation metrics in cases of multiple sclerosis.

Authors:  Radhika Srinivasan; Roland Henry; Daniel Pelletier; Sarah Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Authors:  Ferdinando Squitieri; Sara Orobello; Milena Cannella; Tiziana Martino; Pantaleo Romanelli; Giampiero Giovacchini; Luigi Frati; Luigi Mansi; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.